Steven Cohen acquired 1.39 Million Neurocrine Biosciences shares worth $190 Million. That's 0.55% of their equity portfolio (26th largest holding). The investor owns 1.35% of the outstanding Neurocrine Biosciences stock. The first Neurocrine Biosciences trade was made in Q1 2015. Since then Steven Cohen bought shares sixteen more times and sold shares on fourteen occasions. The stake costed the investor $146 Million, netting the investor a gain of 30% so far.